nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—ABCB1—Mitomycin—stomach cancer	0.0766	0.54	CbGbCtD
Bepridil—ABCB1—Irinotecan—stomach cancer	0.0196	0.138	CbGbCtD
Bepridil—ABCB1—Docetaxel—stomach cancer	0.0144	0.101	CbGbCtD
Bepridil—ABCB1—Doxorubicin—stomach cancer	0.0107	0.0757	CbGbCtD
Bepridil—ABCB1—Methotrexate—stomach cancer	0.0104	0.0733	CbGbCtD
Bepridil—CYP2D6—Doxorubicin—stomach cancer	0.0101	0.0713	CbGbCtD
Bepridil—TNNC1—hematopoietic system—stomach cancer	0.00625	0.0376	CbGeAlD
Bepridil—PDE1A—smooth muscle tissue—stomach cancer	0.00481	0.029	CbGeAlD
Bepridil—ATP1A1—gall bladder—stomach cancer	0.00429	0.0258	CbGeAlD
Bepridil—KCNQ1—pancreas—stomach cancer	0.00413	0.0249	CbGeAlD
Bepridil—CALM2—blood vessel—stomach cancer	0.00401	0.0242	CbGeAlD
Bepridil—CALM1—blood vessel—stomach cancer	0.00399	0.0241	CbGeAlD
Bepridil—CALM2—gall bladder—stomach cancer	0.00378	0.0227	CbGeAlD
Bepridil—CACNA1H—smooth muscle tissue—stomach cancer	0.00375	0.0226	CbGeAlD
Bepridil—PDE1B—endocrine gland—stomach cancer	0.00374	0.0226	CbGeAlD
Bepridil—KCNQ1—digestive system—stomach cancer	0.00353	0.0213	CbGeAlD
Bepridil—KCNQ1—bone marrow—stomach cancer	0.00325	0.0196	CbGeAlD
Bepridil—PDE1A—endocrine gland—stomach cancer	0.00314	0.0189	CbGeAlD
Bepridil—CACNA2D2—endocrine gland—stomach cancer	0.00302	0.0182	CbGeAlD
Bepridil—KCNQ1—endocrine gland—stomach cancer	0.00292	0.0176	CbGeAlD
Bepridil—CACNA1D—pancreas—stomach cancer	0.00287	0.0173	CbGeAlD
Bepridil—CACNA1C—smooth muscle tissue—stomach cancer	0.00286	0.0172	CbGeAlD
Bepridil—PDE1A—liver—stomach cancer	0.00283	0.017	CbGeAlD
Bepridil—KCNQ1—liver—stomach cancer	0.00263	0.0158	CbGeAlD
Bepridil—PDE1B—lymph node—stomach cancer	0.00259	0.0156	CbGeAlD
Bepridil—TNNC1—lymph node—stomach cancer	0.00248	0.0149	CbGeAlD
Bepridil—CACNA1H—endocrine gland—stomach cancer	0.00245	0.0148	CbGeAlD
Bepridil—ATP1A1—hematopoietic system—stomach cancer	0.00243	0.0146	CbGeAlD
Bepridil—CALM3—smooth muscle tissue—stomach cancer	0.0024	0.0144	CbGeAlD
Bepridil—CACNA1C—digestive system—stomach cancer	0.00226	0.0136	CbGeAlD
Bepridil—ATP1A1—epithelium—stomach cancer	0.00222	0.0134	CbGeAlD
Bepridil—CALM3—pancreas—stomach cancer	0.00222	0.0133	CbGeAlD
Bepridil—CACNA1H—liver—stomach cancer	0.00221	0.0133	CbGeAlD
Bepridil—PDE1A—lymph node—stomach cancer	0.00217	0.0131	CbGeAlD
Bepridil—ATP1A1—smooth muscle tissue—stomach cancer	0.00214	0.0129	CbGeAlD
Bepridil—CALM2—hematopoietic system—stomach cancer	0.00214	0.0129	CbGeAlD
Bepridil—CALM1—hematopoietic system—stomach cancer	0.00213	0.0128	CbGeAlD
Bepridil—CACNA2D2—lymph node—stomach cancer	0.00209	0.0126	CbGeAlD
Bepridil—CACNA1D—endocrine gland—stomach cancer	0.00202	0.0122	CbGeAlD
Bepridil—KCNQ1—lymph node—stomach cancer	0.00202	0.0121	CbGeAlD
Bepridil—ATP1A1—pancreas—stomach cancer	0.00198	0.0119	CbGeAlD
Bepridil—CALM2—epithelium—stomach cancer	0.00195	0.0118	CbGeAlD
Bepridil—CALM1—epithelium—stomach cancer	0.00194	0.0117	CbGeAlD
Bepridil—KCNH2—hematopoietic system—stomach cancer	0.00194	0.0117	CbGeAlD
Bepridil—CALM2—smooth muscle tissue—stomach cancer	0.00188	0.0113	CbGeAlD
Bepridil—CALM1—smooth muscle tissue—stomach cancer	0.00187	0.0113	CbGeAlD
Bepridil—CACNA1C—endocrine gland—stomach cancer	0.00187	0.0112	CbGeAlD
Bepridil—CACNA1D—liver—stomach cancer	0.00182	0.011	CbGeAlD
Bepridil—CALM3—bone marrow—stomach cancer	0.00174	0.0105	CbGeAlD
Bepridil—CALM2—pancreas—stomach cancer	0.00174	0.0105	CbGeAlD
Bepridil—CALM1—pancreas—stomach cancer	0.00173	0.0104	CbGeAlD
Bepridil—ATP1A1—lymphoid tissue—stomach cancer	0.00171	0.0103	CbGeAlD
Bepridil—CACNA1H—lymph node—stomach cancer	0.00169	0.0102	CbGeAlD
Bepridil—ATP1A1—digestive system—stomach cancer	0.00169	0.0102	CbGeAlD
Bepridil—ABCB1—blood vessel—stomach cancer	0.00159	0.0096	CbGeAlD
Bepridil—ATP1A1—bone marrow—stomach cancer	0.00156	0.00937	CbGeAlD
Bepridil—CALM2—lymphoid tissue—stomach cancer	0.0015	0.00906	CbGeAlD
Bepridil—CALM1—lymphoid tissue—stomach cancer	0.0015	0.00902	CbGeAlD
Bepridil—CALM2—digestive system—stomach cancer	0.00149	0.00895	CbGeAlD
Bepridil—CALM1—digestive system—stomach cancer	0.00148	0.00891	CbGeAlD
Bepridil—CALM3—liver—stomach cancer	0.00141	0.00849	CbGeAlD
Bepridil—CACNA1D—lymph node—stomach cancer	0.0014	0.00842	CbGeAlD
Bepridil—ATP1A1—endocrine gland—stomach cancer	0.00139	0.0084	CbGeAlD
Bepridil—CALM2—bone marrow—stomach cancer	0.00137	0.00825	CbGeAlD
Bepridil—CALM1—bone marrow—stomach cancer	0.00136	0.00821	CbGeAlD
Bepridil—CACNA1C—lymph node—stomach cancer	0.00129	0.00777	CbGeAlD
Bepridil—ATP1A1—liver—stomach cancer	0.00126	0.00757	CbGeAlD
Bepridil—KCNH2—bone marrow—stomach cancer	0.00124	0.00747	CbGeAlD
Bepridil—CALM2—endocrine gland—stomach cancer	0.00123	0.00739	CbGeAlD
Bepridil—CALM1—endocrine gland—stomach cancer	0.00122	0.00736	CbGeAlD
Bepridil—CYP2D6—hematopoietic system—stomach cancer	0.00118	0.00711	CbGeAlD
Bepridil—KCNH2—endocrine gland—stomach cancer	0.00111	0.0067	CbGeAlD
Bepridil—CALM2—liver—stomach cancer	0.00111	0.00667	CbGeAlD
Bepridil—CALM1—liver—stomach cancer	0.0011	0.00664	CbGeAlD
Bepridil—CALM3—lymph node—stomach cancer	0.00108	0.00651	CbGeAlD
Bepridil—Alverine—HTR1A—stomach cancer	0.000996	0.787	CrCbGaD
Bepridil—ATP1A1—lymph node—stomach cancer	0.000964	0.0058	CbGeAlD
Bepridil—ABCB1—hematopoietic system—stomach cancer	0.000849	0.00511	CbGeAlD
Bepridil—CALM2—lymph node—stomach cancer	0.000849	0.00511	CbGeAlD
Bepridil—CALM1—lymph node—stomach cancer	0.000845	0.00509	CbGeAlD
Bepridil—CYP2D6—digestive system—stomach cancer	0.000821	0.00494	CbGeAlD
Bepridil—ABCB1—epithelium—stomach cancer	0.000776	0.00467	CbGeAlD
Bepridil—KCNH2—lymph node—stomach cancer	0.000769	0.00463	CbGeAlD
Bepridil—Shock—Irinotecan—stomach cancer	0.000715	0.00266	CcSEcCtD
Bepridil—Rhinitis—Docetaxel—stomach cancer	0.000709	0.00264	CcSEcCtD
Bepridil—Cardiac failure—Epirubicin—stomach cancer	0.000707	0.00263	CcSEcCtD
Bepridil—Hyperhidrosis—Irinotecan—stomach cancer	0.000703	0.00261	CcSEcCtD
Bepridil—Pharyngitis—Docetaxel—stomach cancer	0.000702	0.00261	CcSEcCtD
Bepridil—Bradycardia—Capecitabine—stomach cancer	0.000697	0.00259	CcSEcCtD
Bepridil—Oedema—Fluorouracil—stomach cancer	0.000696	0.00259	CcSEcCtD
Bepridil—Anorexia—Irinotecan—stomach cancer	0.000693	0.00258	CcSEcCtD
Bepridil—ABCB1—pancreas—stomach cancer	0.000691	0.00416	CbGeAlD
Bepridil—Rhinitis—Capecitabine—stomach cancer	0.000687	0.00255	CcSEcCtD
Bepridil—Liver function test abnormal—Methotrexate—stomach cancer	0.00068	0.00253	CcSEcCtD
Bepridil—Pharyngitis—Capecitabine—stomach cancer	0.00068	0.00253	CcSEcCtD
Bepridil—Increased appetite—Doxorubicin—stomach cancer	0.000679	0.00253	CcSEcCtD
Bepridil—CYP2D6—endocrine gland—stomach cancer	0.000678	0.00408	CbGeAlD
Bepridil—Anorexia—Fluorouracil—stomach cancer	0.000664	0.00247	CcSEcCtD
Bepridil—Insomnia—Irinotecan—stomach cancer	0.000658	0.00245	CcSEcCtD
Bepridil—Cardiac disorder—Docetaxel—stomach cancer	0.000657	0.00244	CcSEcCtD
Bepridil—Cardiac failure—Doxorubicin—stomach cancer	0.000654	0.00243	CcSEcCtD
Bepridil—Paraesthesia—Irinotecan—stomach cancer	0.000653	0.00243	CcSEcCtD
Bepridil—Dyspnoea—Irinotecan—stomach cancer	0.000648	0.00241	CcSEcCtD
Bepridil—Somnolence—Irinotecan—stomach cancer	0.000646	0.0024	CcSEcCtD
Bepridil—Dyspepsia—Irinotecan—stomach cancer	0.00064	0.00238	CcSEcCtD
Bepridil—Tinnitus—Capecitabine—stomach cancer	0.000639	0.00238	CcSEcCtD
Bepridil—Liver function test abnormal—Epirubicin—stomach cancer	0.000637	0.00237	CcSEcCtD
Bepridil—Cardiac disorder—Capecitabine—stomach cancer	0.000636	0.00236	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000634	0.00236	CcSEcCtD
Bepridil—Decreased appetite—Irinotecan—stomach cancer	0.000632	0.00235	CcSEcCtD
Bepridil—Arrhythmia—Docetaxel—stomach cancer	0.000632	0.00235	CcSEcCtD
Bepridil—Insomnia—Fluorouracil—stomach cancer	0.00063	0.00234	CcSEcCtD
Bepridil—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000628	0.00234	CcSEcCtD
Bepridil—Paraesthesia—Fluorouracil—stomach cancer	0.000625	0.00233	CcSEcCtD
Bepridil—Pain—Irinotecan—stomach cancer	0.000622	0.00231	CcSEcCtD
Bepridil—Constipation—Irinotecan—stomach cancer	0.000622	0.00231	CcSEcCtD
Bepridil—Dyspnoea—Fluorouracil—stomach cancer	0.000621	0.00231	CcSEcCtD
Bepridil—Somnolence—Fluorouracil—stomach cancer	0.000619	0.0023	CcSEcCtD
Bepridil—Dyspepsia—Fluorouracil—stomach cancer	0.000613	0.00228	CcSEcCtD
Bepridil—Arrhythmia—Capecitabine—stomach cancer	0.000612	0.00228	CcSEcCtD
Bepridil—CYP2D6—liver—stomach cancer	0.000611	0.00368	CbGeAlD
Bepridil—Abdominal discomfort—Methotrexate—stomach cancer	0.000611	0.00227	CcSEcCtD
Bepridil—Gastritis—Epirubicin—stomach cancer	0.00061	0.00227	CcSEcCtD
Bepridil—Decreased appetite—Fluorouracil—stomach cancer	0.000605	0.00225	CcSEcCtD
Bepridil—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000601	0.00224	CcSEcCtD
Bepridil—ABCB1—lymphoid tissue—stomach cancer	0.000598	0.0036	CbGeAlD
Bepridil—Influenza—Epirubicin—stomach cancer	0.000596	0.00222	CcSEcCtD
Bepridil—Pain—Fluorouracil—stomach cancer	0.000595	0.00222	CcSEcCtD
Bepridil—Gastrointestinal pain—Irinotecan—stomach cancer	0.000595	0.00221	CcSEcCtD
Bepridil—ABCB1—digestive system—stomach cancer	0.00059	0.00356	CbGeAlD
Bepridil—Liver function test abnormal—Doxorubicin—stomach cancer	0.000589	0.00219	CcSEcCtD
Bepridil—Flatulence—Capecitabine—stomach cancer	0.000587	0.00219	CcSEcCtD
Bepridil—Erectile dysfunction—Methotrexate—stomach cancer	0.000587	0.00218	CcSEcCtD
Bepridil—Angina pectoris—Epirubicin—stomach cancer	0.000581	0.00216	CcSEcCtD
Bepridil—Abdominal pain—Irinotecan—stomach cancer	0.000575	0.00214	CcSEcCtD
Bepridil—Body temperature increased—Irinotecan—stomach cancer	0.000575	0.00214	CcSEcCtD
Bepridil—Drowsiness—Methotrexate—stomach cancer	0.000568	0.00211	CcSEcCtD
Bepridil—Depression—Methotrexate—stomach cancer	0.000566	0.00211	CcSEcCtD
Bepridil—Gastritis—Doxorubicin—stomach cancer	0.000565	0.0021	CcSEcCtD
Bepridil—Vision blurred—Capecitabine—stomach cancer	0.000562	0.00209	CcSEcCtD
Bepridil—Tremor—Capecitabine—stomach cancer	0.000559	0.00208	CcSEcCtD
Bepridil—Syncope—Docetaxel—stomach cancer	0.000552	0.00205	CcSEcCtD
Bepridil—Influenza—Doxorubicin—stomach cancer	0.000552	0.00205	CcSEcCtD
Bepridil—Body temperature increased—Fluorouracil—stomach cancer	0.00055	0.00205	CcSEcCtD
Bepridil—Sweating—Methotrexate—stomach cancer	0.000544	0.00203	CcSEcCtD
Bepridil—ABCB1—bone marrow—stomach cancer	0.000544	0.00328	CbGeAlD
Bepridil—Palpitations—Docetaxel—stomach cancer	0.000544	0.00202	CcSEcCtD
Bepridil—Loss of consciousness—Docetaxel—stomach cancer	0.000541	0.00201	CcSEcCtD
Bepridil—Cough—Docetaxel—stomach cancer	0.000537	0.002	CcSEcCtD
Bepridil—Angina pectoris—Doxorubicin—stomach cancer	0.000537	0.002	CcSEcCtD
Bepridil—Vertigo—Capecitabine—stomach cancer	0.000536	0.00199	CcSEcCtD
Bepridil—Syncope—Capecitabine—stomach cancer	0.000535	0.00199	CcSEcCtD
Bepridil—Hypertension—Docetaxel—stomach cancer	0.000532	0.00198	CcSEcCtD
Bepridil—Drowsiness—Epirubicin—stomach cancer	0.000532	0.00198	CcSEcCtD
Bepridil—Palpitations—Capecitabine—stomach cancer	0.000527	0.00196	CcSEcCtD
Bepridil—Myalgia—Docetaxel—stomach cancer	0.000524	0.00195	CcSEcCtD
Bepridil—Loss of consciousness—Capecitabine—stomach cancer	0.000524	0.00195	CcSEcCtD
Bepridil—Asthenia—Irinotecan—stomach cancer	0.000522	0.00194	CcSEcCtD
Bepridil—Cough—Capecitabine—stomach cancer	0.00052	0.00194	CcSEcCtD
Bepridil—Hypertension—Capecitabine—stomach cancer	0.000515	0.00192	CcSEcCtD
Bepridil—Dry mouth—Docetaxel—stomach cancer	0.000513	0.00191	CcSEcCtD
Bepridil—Sweating—Epirubicin—stomach cancer	0.00051	0.0019	CcSEcCtD
Bepridil—Myalgia—Capecitabine—stomach cancer	0.000508	0.00189	CcSEcCtD
Bepridil—Pharyngitis—Methotrexate—stomach cancer	0.000506	0.00188	CcSEcCtD
Bepridil—Anxiety—Capecitabine—stomach cancer	0.000506	0.00188	CcSEcCtD
Bepridil—Oedema—Docetaxel—stomach cancer	0.000503	0.00187	CcSEcCtD
Bepridil—Diarrhoea—Irinotecan—stomach cancer	0.000497	0.00185	CcSEcCtD
Bepridil—Dry mouth—Capecitabine—stomach cancer	0.000496	0.00185	CcSEcCtD
Bepridil—Shock—Docetaxel—stomach cancer	0.000494	0.00184	CcSEcCtD
Bepridil—Drowsiness—Doxorubicin—stomach cancer	0.000492	0.00183	CcSEcCtD
Bepridil—ABCB1—endocrine gland—stomach cancer	0.000488	0.00294	CbGeAlD
Bepridil—Oedema—Capecitabine—stomach cancer	0.000487	0.00181	CcSEcCtD
Bepridil—Bradycardia—Epirubicin—stomach cancer	0.000486	0.00181	CcSEcCtD
Bepridil—Dizziness—Irinotecan—stomach cancer	0.000481	0.00179	CcSEcCtD
Bepridil—Anorexia—Docetaxel—stomach cancer	0.000479	0.00178	CcSEcCtD
Bepridil—Shock—Capecitabine—stomach cancer	0.000479	0.00178	CcSEcCtD
Bepridil—Rhinitis—Epirubicin—stomach cancer	0.000478	0.00178	CcSEcCtD
Bepridil—Diarrhoea—Fluorouracil—stomach cancer	0.000476	0.00177	CcSEcCtD
Bepridil—Tinnitus—Methotrexate—stomach cancer	0.000475	0.00177	CcSEcCtD
Bepridil—Pharyngitis—Epirubicin—stomach cancer	0.000474	0.00176	CcSEcCtD
Bepridil—Cardiac disorder—Methotrexate—stomach cancer	0.000473	0.00176	CcSEcCtD
Bepridil—Sweating—Doxorubicin—stomach cancer	0.000471	0.00175	CcSEcCtD
Bepridil—Hyperhidrosis—Capecitabine—stomach cancer	0.00047	0.00175	CcSEcCtD
Bepridil—Anorexia—Capecitabine—stomach cancer	0.000464	0.00173	CcSEcCtD
Bepridil—Dizziness—Fluorouracil—stomach cancer	0.00046	0.00171	CcSEcCtD
Bepridil—Rash—Irinotecan—stomach cancer	0.000458	0.00171	CcSEcCtD
Bepridil—Dermatitis—Irinotecan—stomach cancer	0.000458	0.0017	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000458	0.0017	CcSEcCtD
Bepridil—Headache—Irinotecan—stomach cancer	0.000455	0.00169	CcSEcCtD
Bepridil—Insomnia—Docetaxel—stomach cancer	0.000455	0.00169	CcSEcCtD
Bepridil—Paraesthesia—Docetaxel—stomach cancer	0.000451	0.00168	CcSEcCtD
Bepridil—Bradycardia—Doxorubicin—stomach cancer	0.000449	0.00167	CcSEcCtD
Bepridil—Dyspnoea—Docetaxel—stomach cancer	0.000448	0.00167	CcSEcCtD
Bepridil—Somnolence—Docetaxel—stomach cancer	0.000447	0.00166	CcSEcCtD
Bepridil—Tinnitus—Epirubicin—stomach cancer	0.000445	0.00166	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000443	0.00165	CcSEcCtD
Bepridil—Cardiac disorder—Epirubicin—stomach cancer	0.000443	0.00165	CcSEcCtD
Bepridil—Rhinitis—Doxorubicin—stomach cancer	0.000443	0.00165	CcSEcCtD
Bepridil—Dyspepsia—Docetaxel—stomach cancer	0.000442	0.00165	CcSEcCtD
Bepridil—Insomnia—Capecitabine—stomach cancer	0.00044	0.00164	CcSEcCtD
Bepridil—ABCB1—liver—stomach cancer	0.00044	0.00265	CbGeAlD
Bepridil—Rash—Fluorouracil—stomach cancer	0.000439	0.00163	CcSEcCtD
Bepridil—Dermatitis—Fluorouracil—stomach cancer	0.000439	0.00163	CcSEcCtD
Bepridil—Pharyngitis—Doxorubicin—stomach cancer	0.000438	0.00163	CcSEcCtD
Bepridil—Paraesthesia—Capecitabine—stomach cancer	0.000437	0.00163	CcSEcCtD
Bepridil—Decreased appetite—Docetaxel—stomach cancer	0.000437	0.00163	CcSEcCtD
Bepridil—Headache—Fluorouracil—stomach cancer	0.000436	0.00162	CcSEcCtD
Bepridil—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000434	0.00161	CcSEcCtD
Bepridil—Dyspnoea—Capecitabine—stomach cancer	0.000434	0.00161	CcSEcCtD
Bepridil—Nausea—Irinotecan—stomach cancer	0.000432	0.00161	CcSEcCtD
Bepridil—Constipation—Docetaxel—stomach cancer	0.00043	0.0016	CcSEcCtD
Bepridil—Pain—Docetaxel—stomach cancer	0.00043	0.0016	CcSEcCtD
Bepridil—Dyspepsia—Capecitabine—stomach cancer	0.000428	0.00159	CcSEcCtD
Bepridil—Arrhythmia—Epirubicin—stomach cancer	0.000426	0.00159	CcSEcCtD
Bepridil—Decreased appetite—Capecitabine—stomach cancer	0.000423	0.00157	CcSEcCtD
Bepridil—Gastrointestinal disorder—Capecitabine—stomach cancer	0.00042	0.00156	CcSEcCtD
Bepridil—Vision blurred—Methotrexate—stomach cancer	0.000418	0.00156	CcSEcCtD
Bepridil—Constipation—Capecitabine—stomach cancer	0.000416	0.00155	CcSEcCtD
Bepridil—Pain—Capecitabine—stomach cancer	0.000416	0.00155	CcSEcCtD
Bepridil—Nausea—Fluorouracil—stomach cancer	0.000414	0.00154	CcSEcCtD
Bepridil—Tinnitus—Doxorubicin—stomach cancer	0.000412	0.00153	CcSEcCtD
Bepridil—Gastrointestinal pain—Docetaxel—stomach cancer	0.000411	0.00153	CcSEcCtD
Bepridil—Cardiac disorder—Doxorubicin—stomach cancer	0.00041	0.00152	CcSEcCtD
Bepridil—Flatulence—Epirubicin—stomach cancer	0.000409	0.00152	CcSEcCtD
Bepridil—Tension—Epirubicin—stomach cancer	0.000408	0.00152	CcSEcCtD
Bepridil—Nervousness—Epirubicin—stomach cancer	0.000403	0.0015	CcSEcCtD
Bepridil—Vertigo—Methotrexate—stomach cancer	0.000399	0.00148	CcSEcCtD
Bepridil—Gastrointestinal pain—Capecitabine—stomach cancer	0.000398	0.00148	CcSEcCtD
Bepridil—Body temperature increased—Docetaxel—stomach cancer	0.000397	0.00148	CcSEcCtD
Bepridil—Abdominal pain—Docetaxel—stomach cancer	0.000397	0.00148	CcSEcCtD
Bepridil—Arrhythmia—Doxorubicin—stomach cancer	0.000394	0.00147	CcSEcCtD
Bepridil—Vision blurred—Epirubicin—stomach cancer	0.000391	0.00146	CcSEcCtD
Bepridil—Cough—Methotrexate—stomach cancer	0.000387	0.00144	CcSEcCtD
Bepridil—Body temperature increased—Capecitabine—stomach cancer	0.000385	0.00143	CcSEcCtD
Bepridil—Abdominal pain—Capecitabine—stomach cancer	0.000385	0.00143	CcSEcCtD
Bepridil—Flatulence—Doxorubicin—stomach cancer	0.000379	0.00141	CcSEcCtD
Bepridil—Myalgia—Methotrexate—stomach cancer	0.000378	0.00141	CcSEcCtD
Bepridil—Tension—Doxorubicin—stomach cancer	0.000377	0.0014	CcSEcCtD
Bepridil—Nervousness—Doxorubicin—stomach cancer	0.000373	0.00139	CcSEcCtD
Bepridil—Vertigo—Epirubicin—stomach cancer	0.000373	0.00139	CcSEcCtD
Bepridil—Syncope—Epirubicin—stomach cancer	0.000372	0.00139	CcSEcCtD
Bepridil—Palpitations—Epirubicin—stomach cancer	0.000367	0.00137	CcSEcCtD
Bepridil—Loss of consciousness—Epirubicin—stomach cancer	0.000365	0.00136	CcSEcCtD
Bepridil—Cough—Epirubicin—stomach cancer	0.000362	0.00135	CcSEcCtD
Bepridil—Vision blurred—Doxorubicin—stomach cancer	0.000362	0.00135	CcSEcCtD
Bepridil—Asthenia—Docetaxel—stomach cancer	0.000361	0.00134	CcSEcCtD
Bepridil—Hypertension—Epirubicin—stomach cancer	0.000359	0.00133	CcSEcCtD
Bepridil—Myalgia—Epirubicin—stomach cancer	0.000354	0.00132	CcSEcCtD
Bepridil—Anxiety—Epirubicin—stomach cancer	0.000352	0.00131	CcSEcCtD
Bepridil—Hyperhidrosis—Methotrexate—stomach cancer	0.00035	0.0013	CcSEcCtD
Bepridil—Asthenia—Capecitabine—stomach cancer	0.000349	0.0013	CcSEcCtD
Bepridil—Dry mouth—Epirubicin—stomach cancer	0.000346	0.00129	CcSEcCtD
Bepridil—Vertigo—Doxorubicin—stomach cancer	0.000345	0.00128	CcSEcCtD
Bepridil—Anorexia—Methotrexate—stomach cancer	0.000345	0.00128	CcSEcCtD
Bepridil—Syncope—Doxorubicin—stomach cancer	0.000345	0.00128	CcSEcCtD
Bepridil—Diarrhoea—Docetaxel—stomach cancer	0.000344	0.00128	CcSEcCtD
Bepridil—Palpitations—Doxorubicin—stomach cancer	0.00034	0.00126	CcSEcCtD
Bepridil—Oedema—Epirubicin—stomach cancer	0.000339	0.00126	CcSEcCtD
Bepridil—Loss of consciousness—Doxorubicin—stomach cancer	0.000338	0.00126	CcSEcCtD
Bepridil—ABCB1—lymph node—stomach cancer	0.000337	0.00203	CbGeAlD
Bepridil—Cough—Doxorubicin—stomach cancer	0.000335	0.00125	CcSEcCtD
Bepridil—Shock—Epirubicin—stomach cancer	0.000334	0.00124	CcSEcCtD
Bepridil—Diarrhoea—Capecitabine—stomach cancer	0.000333	0.00124	CcSEcCtD
Bepridil—Dizziness—Docetaxel—stomach cancer	0.000332	0.00124	CcSEcCtD
Bepridil—Hypertension—Doxorubicin—stomach cancer	0.000332	0.00123	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.00033	0.00123	CcSEcCtD
Bepridil—Hyperhidrosis—Epirubicin—stomach cancer	0.000328	0.00122	CcSEcCtD
Bepridil—Insomnia—Methotrexate—stomach cancer	0.000328	0.00122	CcSEcCtD
Bepridil—Myalgia—Doxorubicin—stomach cancer	0.000327	0.00122	CcSEcCtD
Bepridil—Anxiety—Doxorubicin—stomach cancer	0.000326	0.00121	CcSEcCtD
Bepridil—Paraesthesia—Methotrexate—stomach cancer	0.000325	0.00121	CcSEcCtD
Bepridil—Anorexia—Epirubicin—stomach cancer	0.000323	0.0012	CcSEcCtD
Bepridil—Dyspnoea—Methotrexate—stomach cancer	0.000323	0.0012	CcSEcCtD
Bepridil—Somnolence—Methotrexate—stomach cancer	0.000322	0.0012	CcSEcCtD
Bepridil—Dizziness—Capecitabine—stomach cancer	0.000322	0.0012	CcSEcCtD
Bepridil—Dry mouth—Doxorubicin—stomach cancer	0.00032	0.00119	CcSEcCtD
Bepridil—Dyspepsia—Methotrexate—stomach cancer	0.000319	0.00119	CcSEcCtD
Bepridil—Rash—Docetaxel—stomach cancer	0.000317	0.00118	CcSEcCtD
Bepridil—Dermatitis—Docetaxel—stomach cancer	0.000317	0.00118	CcSEcCtD
Bepridil—Decreased appetite—Methotrexate—stomach cancer	0.000315	0.00117	CcSEcCtD
Bepridil—Headache—Docetaxel—stomach cancer	0.000315	0.00117	CcSEcCtD
Bepridil—Oedema—Doxorubicin—stomach cancer	0.000314	0.00117	CcSEcCtD
Bepridil—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000313	0.00116	CcSEcCtD
Bepridil—Pain—Methotrexate—stomach cancer	0.00031	0.00115	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000309	0.00115	CcSEcCtD
Bepridil—Shock—Doxorubicin—stomach cancer	0.000309	0.00115	CcSEcCtD
Bepridil—Rash—Capecitabine—stomach cancer	0.000307	0.00114	CcSEcCtD
Bepridil—Insomnia—Epirubicin—stomach cancer	0.000307	0.00114	CcSEcCtD
Bepridil—Dermatitis—Capecitabine—stomach cancer	0.000307	0.00114	CcSEcCtD
Bepridil—Headache—Capecitabine—stomach cancer	0.000305	0.00113	CcSEcCtD
Bepridil—Paraesthesia—Epirubicin—stomach cancer	0.000304	0.00113	CcSEcCtD
Bepridil—Hyperhidrosis—Doxorubicin—stomach cancer	0.000303	0.00113	CcSEcCtD
Bepridil—Dyspnoea—Epirubicin—stomach cancer	0.000302	0.00112	CcSEcCtD
Bepridil—Somnolence—Epirubicin—stomach cancer	0.000301	0.00112	CcSEcCtD
Bepridil—Anorexia—Doxorubicin—stomach cancer	0.000299	0.00111	CcSEcCtD
Bepridil—Nausea—Docetaxel—stomach cancer	0.000299	0.00111	CcSEcCtD
Bepridil—Dyspepsia—Epirubicin—stomach cancer	0.000298	0.00111	CcSEcCtD
Bepridil—Gastrointestinal pain—Methotrexate—stomach cancer	0.000296	0.0011	CcSEcCtD
Bepridil—Decreased appetite—Epirubicin—stomach cancer	0.000295	0.0011	CcSEcCtD
Bepridil—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000293	0.00109	CcSEcCtD
Bepridil—Constipation—Epirubicin—stomach cancer	0.00029	0.00108	CcSEcCtD
Bepridil—Pain—Epirubicin—stomach cancer	0.00029	0.00108	CcSEcCtD
Bepridil—Nausea—Capecitabine—stomach cancer	0.000289	0.00108	CcSEcCtD
Bepridil—Abdominal pain—Methotrexate—stomach cancer	0.000286	0.00107	CcSEcCtD
Bepridil—Body temperature increased—Methotrexate—stomach cancer	0.000286	0.00107	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000286	0.00106	CcSEcCtD
Bepridil—Insomnia—Doxorubicin—stomach cancer	0.000284	0.00106	CcSEcCtD
Bepridil—Paraesthesia—Doxorubicin—stomach cancer	0.000282	0.00105	CcSEcCtD
Bepridil—Dyspnoea—Doxorubicin—stomach cancer	0.00028	0.00104	CcSEcCtD
Bepridil—Somnolence—Doxorubicin—stomach cancer	0.000279	0.00104	CcSEcCtD
Bepridil—Gastrointestinal pain—Epirubicin—stomach cancer	0.000277	0.00103	CcSEcCtD
Bepridil—Dyspepsia—Doxorubicin—stomach cancer	0.000276	0.00103	CcSEcCtD
Bepridil—Decreased appetite—Doxorubicin—stomach cancer	0.000273	0.00101	CcSEcCtD
Bepridil—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000271	0.00101	CcSEcCtD
Bepridil—Phenoxybenzamine—ADRB2—stomach cancer	0.00027	0.213	CrCbGaD
Bepridil—Constipation—Doxorubicin—stomach cancer	0.000268	0.000998	CcSEcCtD
Bepridil—Pain—Doxorubicin—stomach cancer	0.000268	0.000998	CcSEcCtD
Bepridil—Abdominal pain—Epirubicin—stomach cancer	0.000268	0.000997	CcSEcCtD
Bepridil—Body temperature increased—Epirubicin—stomach cancer	0.000268	0.000997	CcSEcCtD
Bepridil—Asthenia—Methotrexate—stomach cancer	0.00026	0.000967	CcSEcCtD
Bepridil—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000256	0.000954	CcSEcCtD
Bepridil—Abdominal pain—Doxorubicin—stomach cancer	0.000248	0.000922	CcSEcCtD
Bepridil—Body temperature increased—Doxorubicin—stomach cancer	0.000248	0.000922	CcSEcCtD
Bepridil—Diarrhoea—Methotrexate—stomach cancer	0.000248	0.000922	CcSEcCtD
Bepridil—Asthenia—Epirubicin—stomach cancer	0.000243	0.000905	CcSEcCtD
Bepridil—Dizziness—Methotrexate—stomach cancer	0.00024	0.000891	CcSEcCtD
Bepridil—Diarrhoea—Epirubicin—stomach cancer	0.000232	0.000863	CcSEcCtD
Bepridil—Rash—Methotrexate—stomach cancer	0.000228	0.00085	CcSEcCtD
Bepridil—Dermatitis—Methotrexate—stomach cancer	0.000228	0.000849	CcSEcCtD
Bepridil—Headache—Methotrexate—stomach cancer	0.000227	0.000844	CcSEcCtD
Bepridil—Asthenia—Doxorubicin—stomach cancer	0.000225	0.000837	CcSEcCtD
Bepridil—Dizziness—Epirubicin—stomach cancer	0.000224	0.000834	CcSEcCtD
Bepridil—Nausea—Methotrexate—stomach cancer	0.000215	0.0008	CcSEcCtD
Bepridil—Diarrhoea—Doxorubicin—stomach cancer	0.000215	0.000798	CcSEcCtD
Bepridil—Rash—Epirubicin—stomach cancer	0.000214	0.000795	CcSEcCtD
Bepridil—Dermatitis—Epirubicin—stomach cancer	0.000214	0.000794	CcSEcCtD
Bepridil—Headache—Epirubicin—stomach cancer	0.000212	0.00079	CcSEcCtD
Bepridil—Dizziness—Doxorubicin—stomach cancer	0.000207	0.000772	CcSEcCtD
Bepridil—Nausea—Epirubicin—stomach cancer	0.000201	0.000749	CcSEcCtD
Bepridil—Rash—Doxorubicin—stomach cancer	0.000198	0.000736	CcSEcCtD
Bepridil—Dermatitis—Doxorubicin—stomach cancer	0.000198	0.000735	CcSEcCtD
Bepridil—Headache—Doxorubicin—stomach cancer	0.000196	0.000731	CcSEcCtD
Bepridil—Nausea—Doxorubicin—stomach cancer	0.000186	0.000693	CcSEcCtD
Bepridil—CALM1—Innate Immune System—PIK3CA—stomach cancer	9.36e-06	2.22e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—RHOA—stomach cancer	9.34e-06	2.21e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—FGFR2—stomach cancer	9.33e-06	2.21e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—FGFR2—stomach cancer	9.33e-06	2.21e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—HRAS—stomach cancer	9.29e-06	2.2e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—PIK3CA—stomach cancer	9.29e-06	2.2e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—NOS3—stomach cancer	9.24e-06	2.19e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—PIK3CA—stomach cancer	9.19e-06	2.18e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—TYMS—stomach cancer	9.07e-06	2.15e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—ERBB2—stomach cancer	9.06e-06	2.15e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—ERBB2—stomach cancer	9.06e-06	2.15e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—RHOA—stomach cancer	9.03e-06	2.14e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—RHOA—stomach cancer	9.03e-06	2.14e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PPARG—stomach cancer	9e-06	2.13e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—PIK3CA—stomach cancer	8.98e-06	2.13e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—PIK3CA—stomach cancer	8.98e-06	2.13e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—GSTM1—stomach cancer	8.97e-06	2.12e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—HRAS—stomach cancer	8.95e-06	2.12e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—ERCC2—stomach cancer	8.95e-06	2.12e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—NOS3—stomach cancer	8.94e-06	2.12e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—NOS3—stomach cancer	8.94e-06	2.12e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—IL6—stomach cancer	8.89e-06	2.11e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—TP53—stomach cancer	8.89e-06	2.11e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IRS2—stomach cancer	8.83e-06	2.09e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PPARG—stomach cancer	8.71e-06	2.06e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PPARG—stomach cancer	8.71e-06	2.06e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—CDKN1B—stomach cancer	8.67e-06	2.05e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—HRAS—stomach cancer	8.66e-06	2.05e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—HRAS—stomach cancer	8.66e-06	2.05e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—ERBB2—stomach cancer	8.65e-06	2.05e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—HRAS—stomach cancer	8.59e-06	2.04e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—IL6—stomach cancer	8.57e-06	2.03e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CAV1—stomach cancer	8.56e-06	2.03e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—APOA1—stomach cancer	8.54e-06	2.02e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IRS2—stomach cancer	8.54e-06	2.02e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IRS2—stomach cancer	8.54e-06	2.02e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL1B—stomach cancer	8.52e-06	2.02e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—HRAS—stomach cancer	8.5e-06	2.01e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—PTGS2—stomach cancer	8.45e-06	2e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—ERCC2—stomach cancer	8.43e-06	2e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—MTHFR—stomach cancer	8.41e-06	1.99e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—CDKN1B—stomach cancer	8.39e-06	1.99e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—CDKN1B—stomach cancer	8.39e-06	1.99e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—ERBB2—stomach cancer	8.36e-06	1.98e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—ERBB2—stomach cancer	8.36e-06	1.98e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—HRAS—stomach cancer	8.31e-06	1.97e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—HRAS—stomach cancer	8.31e-06	1.97e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—IL6—stomach cancer	8.29e-06	1.96e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—IL6—stomach cancer	8.29e-06	1.96e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CAV1—stomach cancer	8.28e-06	1.96e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CAV1—stomach cancer	8.28e-06	1.96e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—APOA1—stomach cancer	8.26e-06	1.96e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—APOA1—stomach cancer	8.26e-06	1.96e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—JUN—stomach cancer	8.26e-06	1.96e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL1B—stomach cancer	8.24e-06	1.95e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL1B—stomach cancer	8.24e-06	1.95e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—PTGS2—stomach cancer	8.18e-06	1.94e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—PTGS2—stomach cancer	8.18e-06	1.94e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PRKCB—stomach cancer	8.15e-06	1.93e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—IL6—stomach cancer	8.13e-06	1.93e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL6ST—stomach cancer	8.12e-06	1.92e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—ALB—stomach cancer	8.09e-06	1.92e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—CDKN1B—stomach cancer	8.01e-06	1.9e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—CDKN1A—stomach cancer	8e-06	1.9e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—JUN—stomach cancer	7.99e-06	1.89e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—JUN—stomach cancer	7.99e-06	1.89e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—MTHFR—stomach cancer	7.93e-06	1.88e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PRKCB—stomach cancer	7.88e-06	1.87e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PRKCB—stomach cancer	7.88e-06	1.87e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL6ST—stomach cancer	7.85e-06	1.86e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL6ST—stomach cancer	7.85e-06	1.86e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—ALB—stomach cancer	7.83e-06	1.85e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—ALB—stomach cancer	7.83e-06	1.85e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—MAPK8—stomach cancer	7.81e-06	1.85e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—APC—stomach cancer	7.8e-06	1.85e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CAV1—stomach cancer	7.76e-06	1.84e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—CDKN1B—stomach cancer	7.75e-06	1.84e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—CDKN1B—stomach cancer	7.75e-06	1.84e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—CDKN1A—stomach cancer	7.74e-06	1.83e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—CDKN1A—stomach cancer	7.74e-06	1.83e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—APOA1—stomach cancer	7.74e-06	1.83e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—NOS3—stomach cancer	7.74e-06	1.83e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—MAPK8—stomach cancer	7.56e-06	1.79e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—MAPK8—stomach cancer	7.56e-06	1.79e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—APC—stomach cancer	7.54e-06	1.79e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—APC—stomach cancer	7.54e-06	1.79e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—NOS3—stomach cancer	7.49e-06	1.77e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—NOS3—stomach cancer	7.49e-06	1.77e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—MAPK3—stomach cancer	7.47e-06	1.77e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—CDKN1A—stomach cancer	7.39e-06	1.75e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CAV1—stomach cancer	7.31e-06	1.73e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—APOA1—stomach cancer	7.29e-06	1.73e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL6R—stomach cancer	7.24e-06	1.72e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—MAPK3—stomach cancer	7.22e-06	1.71e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—MAPK3—stomach cancer	7.22e-06	1.71e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—CDKN1A—stomach cancer	7.15e-06	1.69e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—CDKN1A—stomach cancer	7.15e-06	1.69e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—STAT3—stomach cancer	7.14e-06	1.69e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—MAPK1—stomach cancer	7.11e-06	1.68e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—EGFR—stomach cancer	7.1e-06	1.68e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PTGS2—stomach cancer	7.08e-06	1.68e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL6R—stomach cancer	7e-06	1.66e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL6R—stomach cancer	7e-06	1.66e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—STAT3—stomach cancer	6.91e-06	1.64e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—STAT3—stomach cancer	6.91e-06	1.64e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—MAPK1—stomach cancer	6.87e-06	1.63e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—MAPK1—stomach cancer	6.87e-06	1.63e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—EGFR—stomach cancer	6.87e-06	1.63e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—EGFR—stomach cancer	6.87e-06	1.63e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PTGS2—stomach cancer	6.85e-06	1.62e-05	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PTGS2—stomach cancer	6.85e-06	1.62e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—MAPK3—stomach cancer	6.82e-06	1.62e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PPARG—stomach cancer	6.82e-06	1.62e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—SERPINE1—stomach cancer	6.78e-06	1.61e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—KRAS—stomach cancer	6.71e-06	1.59e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—MAPK3—stomach cancer	6.6e-06	1.56e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—MAPK3—stomach cancer	6.6e-06	1.56e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—STAT3—stomach cancer	6.59e-06	1.56e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—SERPINE1—stomach cancer	6.56e-06	1.55e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—SERPINE1—stomach cancer	6.56e-06	1.55e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—RHOA—stomach cancer	6.54e-06	1.55e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—MAPK1—stomach cancer	6.49e-06	1.54e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—KRAS—stomach cancer	6.49e-06	1.54e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—KRAS—stomach cancer	6.49e-06	1.54e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—EGFR—stomach cancer	6.49e-06	1.54e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—NOS3—stomach cancer	6.47e-06	1.53e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PPARG—stomach cancer	6.43e-06	1.52e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—STAT3—stomach cancer	6.38e-06	1.51e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—STAT3—stomach cancer	6.38e-06	1.51e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—RHOA—stomach cancer	6.33e-06	1.5e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—RHOA—stomach cancer	6.33e-06	1.5e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—MAPK3—stomach cancer	6.3e-06	1.49e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—MAPK1—stomach cancer	6.28e-06	1.49e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—MAPK1—stomach cancer	6.28e-06	1.49e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—EGFR—stomach cancer	6.28e-06	1.49e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—EGFR—stomach cancer	6.28e-06	1.49e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NOS3—stomach cancer	6.26e-06	1.48e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NOS3—stomach cancer	6.26e-06	1.48e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—PIK3CA—stomach cancer	6.17e-06	1.46e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—ALB—stomach cancer	6.13e-06	1.45e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—KRAS—stomach cancer	6.13e-06	1.45e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—MYC—stomach cancer	6.13e-06	1.45e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—MAPK3—stomach cancer	6.09e-06	1.44e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—MAPK3—stomach cancer	6.09e-06	1.44e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—ERBB2—stomach cancer	6.05e-06	1.43e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—MAPK1—stomach cancer	5.99e-06	1.42e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—EGFR—stomach cancer	5.99e-06	1.42e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—PIK3CA—stomach cancer	5.96e-06	1.41e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—PIK3CA—stomach cancer	5.96e-06	1.41e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—KRAS—stomach cancer	5.93e-06	1.41e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—KRAS—stomach cancer	5.93e-06	1.41e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—MYC—stomach cancer	5.93e-06	1.4e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—MYC—stomach cancer	5.93e-06	1.4e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—NOS3—stomach cancer	5.87e-06	1.39e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—ERBB2—stomach cancer	5.86e-06	1.39e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—ERBB2—stomach cancer	5.86e-06	1.39e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—MAPK1—stomach cancer	5.8e-06	1.37e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—MAPK1—stomach cancer	5.8e-06	1.37e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—EGFR—stomach cancer	5.8e-06	1.37e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—EGFR—stomach cancer	5.8e-06	1.37e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—ALB—stomach cancer	5.78e-06	1.37e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CXCL8—stomach cancer	5.74e-06	1.36e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—HRAS—stomach cancer	5.7e-06	1.35e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—KRAS—stomach cancer	5.66e-06	1.34e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—PIK3CA—stomach cancer	5.63e-06	1.33e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CDKN1B—stomach cancer	5.61e-06	1.33e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CXCL8—stomach cancer	5.55e-06	1.32e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CXCL8—stomach cancer	5.55e-06	1.32e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—NOS3—stomach cancer	5.53e-06	1.31e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—HRAS—stomach cancer	5.52e-06	1.31e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—HRAS—stomach cancer	5.52e-06	1.31e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—KRAS—stomach cancer	5.48e-06	1.3e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—KRAS—stomach cancer	5.48e-06	1.3e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—IL6—stomach cancer	5.46e-06	1.29e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—PIK3CA—stomach cancer	5.45e-06	1.29e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—PIK3CA—stomach cancer	5.45e-06	1.29e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CDKN1B—stomach cancer	5.42e-06	1.29e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CDKN1B—stomach cancer	5.42e-06	1.29e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PTGS2—stomach cancer	5.37e-06	1.27e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CCND1—stomach cancer	5.35e-06	1.27e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—JUN—stomach cancer	5.34e-06	1.26e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—IL6—stomach cancer	5.28e-06	1.25e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—IL6—stomach cancer	5.28e-06	1.25e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—HRAS—stomach cancer	5.21e-06	1.23e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—PIK3CA—stomach cancer	5.2e-06	1.23e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MMP9—stomach cancer	5.19e-06	1.23e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CDKN1A—stomach cancer	5.17e-06	1.23e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CCND1—stomach cancer	5.17e-06	1.23e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CCND1—stomach cancer	5.17e-06	1.23e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—JUN—stomach cancer	5.16e-06	1.22e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—JUN—stomach cancer	5.16e-06	1.22e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PTGS2—stomach cancer	5.06e-06	1.2e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MAPK8—stomach cancer	5.05e-06	1.2e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—HRAS—stomach cancer	5.04e-06	1.19e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—HRAS—stomach cancer	5.04e-06	1.19e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—PIK3CA—stomach cancer	5.03e-06	1.19e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—PIK3CA—stomach cancer	5.03e-06	1.19e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MMP9—stomach cancer	5.02e-06	1.19e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MMP9—stomach cancer	5.02e-06	1.19e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CDKN1A—stomach cancer	5.01e-06	1.19e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CDKN1A—stomach cancer	5.01e-06	1.19e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL6—stomach cancer	4.99e-06	1.18e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MAPK8—stomach cancer	4.89e-06	1.16e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MAPK8—stomach cancer	4.89e-06	1.16e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL6—stomach cancer	4.83e-06	1.14e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL6—stomach cancer	4.83e-06	1.14e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—HRAS—stomach cancer	4.81e-06	1.14e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—VEGFA—stomach cancer	4.66e-06	1.1e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—HRAS—stomach cancer	4.66e-06	1.1e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—HRAS—stomach cancer	4.66e-06	1.1e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—STAT3—stomach cancer	4.62e-06	1.09e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—IL6—stomach cancer	4.61e-06	1.09e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—VEGFA—stomach cancer	4.51e-06	1.07e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—VEGFA—stomach cancer	4.51e-06	1.07e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—STAT3—stomach cancer	4.47e-06	1.06e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—STAT3—stomach cancer	4.47e-06	1.06e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—IL6—stomach cancer	4.46e-06	1.06e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—IL6—stomach cancer	4.46e-06	1.06e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MAPK3—stomach cancer	4.41e-06	1.05e-05	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PIK3CA—stomach cancer	4.36e-06	1.03e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MYC—stomach cancer	4.29e-06	1.02e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MAPK3—stomach cancer	4.27e-06	1.01e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MAPK3—stomach cancer	4.27e-06	1.01e-05	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PIK3CA—stomach cancer	4.21e-06	9.98e-06	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PIK3CA—stomach cancer	4.21e-06	9.98e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MAPK1—stomach cancer	4.2e-06	9.94e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—EGFR—stomach cancer	4.2e-06	9.94e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MYC—stomach cancer	4.15e-06	9.83e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MYC—stomach cancer	4.15e-06	9.83e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MAPK1—stomach cancer	4.06e-06	9.62e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MAPK1—stomach cancer	4.06e-06	9.62e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—EGFR—stomach cancer	4.06e-06	9.62e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—EGFR—stomach cancer	4.06e-06	9.62e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—KRAS—stomach cancer	3.96e-06	9.39e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—KRAS—stomach cancer	3.84e-06	9.09e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—KRAS—stomach cancer	3.84e-06	9.09e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PIK3CA—stomach cancer	3.64e-06	8.63e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TP53—stomach cancer	3.52e-06	8.35e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PIK3CA—stomach cancer	3.52e-06	8.35e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PIK3CA—stomach cancer	3.52e-06	8.35e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TP53—stomach cancer	3.41e-06	8.08e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TP53—stomach cancer	3.41e-06	8.08e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—HRAS—stomach cancer	3.37e-06	7.98e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PIK3CA—stomach cancer	3.3e-06	7.82e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—HRAS—stomach cancer	3.26e-06	7.72e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—HRAS—stomach cancer	3.26e-06	7.72e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL6—stomach cancer	3.23e-06	7.64e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL6—stomach cancer	3.12e-06	7.39e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL6—stomach cancer	3.12e-06	7.39e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PIK3CA—stomach cancer	3.11e-06	7.37e-06	CbGpPWpGaD
